Results 121 to 130 of about 147,672 (267)

Reclassifying Papillary, Oncocytic and Chromophobe Renal Tumours Based on the 5thWho Classification 2022 [PDF]

open access: yesTürk Patoloji Dergisi
Objective: The classification of renal tumors is expanding with the addition of new molecular entities in the 5th World Health Organization classification.
Nilofar SHAIKH, Mary MATHEW
doaj   +1 more source

PARP Inhibitors in Genitourinary Cancer: A New Paradigm Beyond Prostate Cancer

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Alterations in the homologous recombination repair genes, such as BRCA1 and BRCA2, are prevalent in various cancers, presenting a unique opportunity to develop synthetic lethal strategies that target homologous recombination deficiency (HRD).
Yohei Okuda   +8 more
wiley   +1 more source

Prognostic models in papillary renal cell carcinoma [PDF]

open access: yesAnnals of Translational Medicine, 2020
A. Ari Hakimi   +2 more
openaire   +3 more sources

Tubulocystic carcinoma of kidney associated with papillary renal cell carcinoma

open access: yesIndian Journal of Pathology and Microbiology, 2011
Tubulocystic renal cell carcinoma (TCRCC) is a rare variant of renal cell carcinoma, which has distinct histology but there is some controversy about its association with papillary renal cell carcinoma (PRCC) and cell of origin in literature. We report an 18-year-old girl with the rare TCRCC of kidney associated with PRCC with metastases to the para ...
Mahesh Deshmukh   +3 more
openaire   +4 more sources

Using deep learning to differentiate among histology renal tumor types in computed tomography scans

open access: yesBMC Medical Imaging
Background This study employed a convolutional neural network (CNN) to analyze computed tomography (CT) scans with the aim of differentiating among renal tumors according to histologic sub-type.
Hung-Cheng Kan   +12 more
doaj   +1 more source

A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas [PDF]

open access: bronze, 2004
Zhen-Hua Lin   +6 more
openalex   +1 more source

Impact of Estimated Glomerular Filtration Rate and Serum C‐Reactive Protein Level to Overall Survival After Second‐Line Targeted Therapy Following Immuno‐Oncology Combination Therapy for Advanced Renal Cell Carcinoma

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Objectives Immune checkpoint inhibitor (ICI)‐based combination therapies are first‐line treatments for locally advanced or metastatic renal cell carcinoma (mRCC). However, second‐line treatment efficacy remains uncertain due to limited large randomized trials. This study evaluated real‐world oncological outcomes after second‐line treatments in
Keita Nakane   +8 more
wiley   +1 more source

Molecular Genetic Evidence for the Independent Origin of Multifocal Papillary Tumors in Patients with Papillary Renal Cell Carcinomas [PDF]

open access: bronze, 2005
Timothy D. Jones   +12 more
openalex   +1 more source

Current Evidences and Future Perspectives in the Management of Metastatic Non‐Clear Cell Renal Cell Carcinoma

open access: yesInternational Journal of Urology, EarlyView.
ABSTRACT Renal cell carcinoma is a heterogeneous disease with diverse phenotypes. Renal cell carcinoma classification is based on morphological and molecular characteristics and falls into 2 main categories: clear cell renal cell carcinoma and non‐clear cell renal cell carcinoma.
Shotaro Nakanishi, Junichi Inokuchi
wiley   +1 more source

Home - About - Disclaimer - Privacy